Drug Companies Update November 2008
Mergers, acquisitions & Joint Ventures
- Dr Reddy's acquired Perlecan Pharma.
New Companies
- 4-antibody is a biotechnology company developing fully-human antibodies, for the treatment of autoimmune and inflammatory diseases as well as cancer.
- Adeona Pharmaceuticals develops autoimmune therapeutics.
- China-based Botanic Century is engaged in the development of plant-based on traditional Chinese medicine for the treatment of a variety of diseases.
- Esperance Pharmaceuticals is a biopharmaceutical company developing selective and targeted anticancer drugs.
- HemCon is a technology company focused on wound healing.
- Integrated BioTherapeutics is engaged in the development of anti-infective vaccines and drugs for biodefense and infectious diseases.
- LEAD Therapeutics is a small molecule drug discovery company focused on the development of treatments for cancer and infectious diseases.
- Leuchemix is a minority owned subsidiary of Combimatrix. It develops anticancer therapeutics.
- Spanish oufit Lipopharma is involved in the development of Membrane Lipid Therapies
- Mystic Pharmaceuticals combines its drug delivery technologies with small molecule pharmaceuticals, biological agents and vaccines.
- Tetraphase Pharmaceuticals discovers and develops novel antibiotics to treat drug-resistant infections, as well as therapeutics for inflammation and oncology.
